NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
64 hedge funds and large institutions have $14M invested in Nymox Pharmaceutical Corp in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less call options, than puts
Call options by funds: $55K | Put options by funds: $99K
Holders
64
Holding in Top 10
–
Calls
$55K
Puts
$99K
Top Buyers
| 1 | +$250K | |
| 2 | +$202K | |
| 3 | +$182K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$169K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$47K |
Top Sellers
| 1 | -$123K | |
| 2 | -$110K | |
| 3 | -$99.1K | |
| 4 |
SG Americas Securities
New York
|
-$76K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$63K |